HOX genes: Role in colon cancer development

Colon cancer is a leading cause of cancer-related deaths in not only the United States, but all over the globe. Conventional research over the last 50 years has shown that tumors undergo a series of genetic mutations that lead to the unchecked growth of tumors and their progression to metastatic cancer. Traditional therapies designed to kill the bulk of cancer tumor cells continue to fall short of a cure for advanced, drug-resistant colon cancers.
Over-expression of HOXA4 and HOXA9 genes in colon cancer stem cells promotes cell replication and contributes to the overpopulation of stem cells that drives colon cancer development. The findings suggest treatment with vitamin A derivatives, called retinoid drugs, could provide a therapeutic strategy for decreasing the expression of these HOX genes and for targeting highly resistant cancer stem cells. These long-lived, uncommon cells start out as tissue stem cells that become cancer stem cells when certain mutations or mistakes occur in the genes that regulate cell renewal and overpopulation. These genes are known to be master regulators of stem cells, and because HOX gene expression has been found to malfunction in various types of cancer.
Gene expression works as an on/off switch that regulates how cellular components are made. Adjusting the level of gene expression can directly impact cancer cell development and the drive to self-replicate. What discovered was that lowering HOXA4 or HOXA9 expression in colon cancer stem cells decreases their self-renewal ability, reducing cell population, and inhibiting cell proliferation. Therapeutically focusing on HOX gene expression could diminish the self-renewal capacity of malignant stem cells amid cancer advancement. To test this hypothesis, they chose All-Trans Retinoic Acid (ATRA), one of the most commonly explored and clinically tested retinoic acid derivatives. ATRA regulates HOX gene expression, diminishes gene expression of a known stem cell biomarker (ALDH1) and decrease stem cell renewal.
17th International Conference on Gastroenterology and Hepatology is scheduled during September 03-04, 2018 in Dubai, UAE.
For more details:
Anna Harper
Program Manager

Comments

Popular posts from this blog

A healthy gut : better recovery from spinal cord injury

World Breast-Feeding Week 2018: Breast-feeding's Role in 'Seeding' Infant Microbiome